Algert Global’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $473K | Buy |
+10,850
| New | +$473K | 0.01% | 946 |
|
|
2024
Q4 | – | Sell |
-30,256
| Closed | -$1.43M | – | 1253 |
|
|
2024
Q3 | $1.43M | Sell |
30,256
-2,450
| -7% | -$116K | 0.04% | 671 |
|
|
2024
Q2 | $976K | Buy |
32,706
+4,622
| +16% | +$138K | 0.03% | 694 |
|
|
2024
Q1 | $1.13M | Sell |
28,084
-71,288
| -72% | -$2.87M | 0.04% | 584 |
|
|
2023
Q4 | $2.53M | Sell |
99,372
-29,160
| -23% | -$742K | 0.1% | 336 |
|
|
2023
Q3 | $1.79M | Buy |
128,532
+72,802
| +131% | +$1.01M | 0.08% | 400 |
|
|
2023
Q2 | $1.28M | Buy |
+55,730
| New | +$1.28M | 0.06% | 566 |
|
|
2022
Q2 | – | Sell |
-8,242
| Closed | -$349K | – | 1303 |
|
|
2022
Q1 | $349K | Buy |
8,242
+3,591
| +77% | +$152K | 0.02% | 931 |
|
|
2021
Q4 | $295K | Buy |
4,651
+440
| +10% | +$27.9K | 0.04% | 734 |
|
|
2021
Q3 | $247K | Buy |
+4,211
| New | +$247K | 0.03% | 829 |
|